The NETRF 2017 Grant opportunities Request for Application is now open
July 05, 2017|
The Neuroendocrine Tumor Research Foundation (NETRF), USA, has announced a new round of scientific and clinical research grants, aimed at advancing the treatment of and the search for cures to neuroendocrine tumors (NETs).
The research grants fall into three categories: Accelerator Grants, Investigator Grants, and Pilot Project Grants. Made possible in part by a generous gift from the Margie and Robert E. Petersen Foundation, the grants vary from $50,000 to $1.2 million and run up to four years.
“These are significant grants meant to transform our progress and continue our commitment to attract and support a committed community of investigators dedicated to a cure,” said Ron Hollander, NETRF executive director. “We are looking to attract the best ideas and the brightest researchers and physicians whose work can have a rapid impact on improving care for NET patients.”
“In our 2017 grants, we focused on funding teams that could help us unlock the biologic and genomic drivers that cause these tumors to form and grow,” said George Fisher, M.D., Ph.D., co-chair, NETRF Board of Scientific Advisors. “For our 2018 grants, we are looking for a broad range of research – especially translational and clinical projects──that can lead to better therapeutics improving the lives of our patients.”
“There have been many recent discoveries that have changed the way some cancers are diagnosed and treated,” said Daniel Chung, M.D., co-chair, NETRF Board of Scientific Advisors. “But the treatment of NETs lags behind. We need to accelerate our search for effective treatments and are looking for transformative ideas.”
NETRF uses a rigorous peer review process that includes external expert reviewers and a Board of Scientific Advisors to select award winners. Interested applicants must submit a letter of intent by September 5, 2017. Grant awards will be announced in early 2018.